This inventor holds 2 USPTO granted patents. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 1980-1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980-1985
Title: The Innovations of Hiroaki Hamano: A Look at His Patents and Contributions
Introduction: Hiroaki Hamano, a notable inventor based in Higashimurayama, Japan, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Hamano's work focuses on the development of innovative compounds that have the potential to advance medical treatments.
Latest Patents: Hamano's latest patents include a derivative of cephamycin C, which presents an N-benzenesulfonyl derivative capable of being separated as a solid from an aqueous solution. This derivative serves as an intermediate for creating cephamycin-type antibiotic substances, showcasing its valuable role in the fight against bacterial infections. Another significant patent involves derivatives of α-methyl-β-aminopropiophenone, which possess bronchodilator activity. These novel compounds have versatile structural characteristics, allowing for various therapeutic applications, particularly in airway-related disorders.
Career Highlights: Hiroaki Hamano has dedicated his career to pharmaceutical research and development. Currently, he is affiliated with Nippon Kayaku Co., Ltd., a prominent player in the pharmaceutical industry. His dedication to innovation has led to significant advancements in drug development, particularly in the creation of effective therapeutic agents.
Collaborations: Throughout his career, Hamano has worked alongside esteemed colleagues like Akira Shiozawa and Shuji Kurashige. Their collaborative efforts have fostered an environment of creativity and innovation, enabling the team to explore new scientific frontiers in the realm of medicinal chemistry.
Conclusion: Hiroaki Hamano's contributions to pharmaceutical innovation through his patents reflect his commitment to enhancing healthcare. His work on cephamycin derivatives and bronchodilator compounds demonstrates the potential impact that dedicated inventors can have in advancing both medicine and patient care. As he continues to push boundaries in research, the implications of his inventions hold promise for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
